International Psoriasis Council
Advancing Knowledge. Improving Care.
Learn how psoriasis severity is defined and what NPF’s endorsement of IPC’s framework means for classifying mild versus moderate to
Three IPC community members were honored with 2025 ILDS awards for their humanitarian work and leadership in dermatology. Learn more
Discover the new free psoriasis course on WHOAcademy, created by IPC and IFPA for the WHO. Enhance your knowledge of
Empowering women leaders in dermatology, the Emerging Women Leaders in Inflammatory Skin Diseases course provides essential skills for authoritative influence,
Join us in honoring the life and legacy of Dr. Hoseah Waweru, esteemed President of IFPA, whose dedication and compassion
Highlighting a decade of psoriasis advocacy. IPC is pleased to join IFPA in celebrating the 20th anniversary of the World
Explore the impact of psoriasis on global public health and the latest addition of methotrexate for managing moderate to severe
The IPC is proud to announce a collaboration with the National Psoriasis Foundation (NPF) in unveiling new insights into the
The University of Oxford seeks 2000 psoriasis volunteers for a groundbreaking study exploring the link between the skin condition and
The Global Psoriasis Atlas (GPA) is a joint project of the ILDS (International League of Dermatological Societies), IFPA (International Federation
According to a new paper published by the team behind the PsoProtect registry, psoriasis patients treated with biologics are at
In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.
What were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis therapies, and late-breaking research from leading experts.
A new regional collaboration led by IPC and partner organizations aims to improve diagnosis, treatment, and care coordination for psoriasis and psoriatic arthritis across Latin America.
IPC recognizes its 2025 Fellows as IPC Jr. Councilors following the completion of their fellowship. This transition recognizes their contributions to psoriasis research, education, and global collaboration, and marks their expanded role in the IPC network.
The International Psoriasis Council welcomes Mari Løset and Maxwell Sauder as new Councilors, supporting IPC’s global mission in psoriasis research and care.
In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.